Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Updates in the ABC5 guidelines for the treatment of luminal metastatic breast cancer

Prof Nagi El Saghir - American University of Beirut Medical Center, Beirut, Lebanon
Updates in the ABC5 guidelines for the treatment of luminal metastatic breast cancer ( Prof Nagi El Saghir - American University of Beirut Medical Center, Beirut, Lebanon )
27 Jan 2020

Current controversies in breast cancer treatment

Prof Matti Aapro - Genolier Cancer Centre, Genolier, Switzerland
Current controversies in breast cancer treatment ( Prof Matti Aapro - Genolier Cancer Centre, Genolier, Switzerland )
27 Jan 2020

Highlights from BGICC 2020

Prof. Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
Highlights from BGICC 2020 ( Prof. Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt )
27 Jan 2020

PARP inhibitors and immunotherapy in ovarian cancer: From research to practice

PARP inhibitors and immunotherapy in ovarian cancer: From research to practice (  )
27 Jan 2020

The age of genomic profiling

Prof Cengiz Yakicier - Acıbadem University, Istanbul, Turkey
The age of genomic profiling ( Prof Cengiz Yakicier - Acıbadem University, Istanbul, Turkey )
27 Jan 2020

Identifying BRCA mutations for breast and ovarian cancer

Prof Alena Savanevich - Grodno State Medical University, Grodno, Belarus
Identifying BRCA mutations for breast and ovarian cancer ( Prof Alena Savanevich - Grodno State Medical University, Grodno, Belarus )
27 Jan 2020

Long-term toxicities in paediatric ALL

Prof Kjeld Schmiegelow - University of Copenhagen, Copenhagen, Denmark
Long-term toxicities in paediatric ALL ( Prof Kjeld Schmiegelow - University of Copenhagen, Copenhagen, Denmark )
23 Jan 2020

HER2CLIMB: Investigating tucatinib with capecitabine and trastuzumab in HER2-positive metastatic breast cancer

Dr Rashmi Murthy - MD Anderson Cancer Center, Houston, USA
HER2CLIMB: Investigating tucatinib with capecitabine and trastuzumab in HER2-positive metastatic breast cancer ( Dr Rashmi Murthy - MD Anderson Cancer Center, Houston, USA )
23 Jan 2020

Novel therapeutic approaches in B-progenitor ALL

Dr Charles Mullighan - St. Jude's Children's Research Hospital, Memphis, USA
Novel therapeutic approaches in B-progenitor ALL ( Dr Charles Mullighan - St. Jude's Children's Research Hospital, Memphis, USA )
23 Jan 2020

Latest concepts in frontline therapy for paediatric ALL

Dr Ching-Hon Pui - St Jude's Children's Research Hospital, Memphis, USA
Latest concepts in frontline therapy for paediatric ALL ( Dr Ching-Hon Pui - St Jude's Children's Research Hospital, Memphis, USA )
23 Jan 2020

Is enasidenib plus azacitidine better than with azacitidine alone for AML patients?

Dr Courtney DiNardo - MD Anderson Cancer Center, Houston, USA
Is enasidenib plus azacitidine better than with azacitidine alone for AML patients? ( Dr Courtney DiNardo - MD Anderson Cancer Center, Houston, USA )
24 Dec 2019

Lenalidomide maintenance for transplant eligible and transplant ineligible newly diagnosed myeloma patients

Dr Charlotte Pawlyn - Institute of Cancer Research, London, UK
Lenalidomide maintenance for transplant eligible and transplant ineligible newly diagnosed myeloma patients ( Dr Charlotte Pawlyn - Institute of Cancer Research, London, UK )
24 Dec 2019